El Camino Hospital Pioneers First U.S. Use of Robotic Platform for Lung Cancer Diagnosis

The Taft Center for Clinical Research at El Camino Hospital announced that its interventional pulmonology team has successfully performed an innovative robotic bronchoscopy procedure to view the inside of the lungs and obtain a tissue sample.
a year ago

12 April 2018 - MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)

The Taft Center for Clinical Research at El Camino Hospital is pleased to announce that its interventional pulmonology team has successfully performed an innovative robotic bronchoscopy procedure to view the inside of the lungs and obtain a tissue sample. This procedure, the first of its kind performed in the United States, took place as part of a clinical trial of Auris Health’s Monarch Platform. Auris recently announced U.S. Food and Drug Administration (FDA) clearance of the platform.

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women and often the leading cause of cancer deaths in the United States, having a higher mortality than prostate, colon, and breast cancers combined. Approximately 220,000 people are newly diagnosed with lung cancer each year and more than 155,000 people die from the disease annually in the United States. The early and accurate diagnosis of lung cancer is critical. Today, 90 percent of people who have lung cancer die from the disease, in part because it is often not found until the cancer is at an advanced stage. As the technology to identify lesions improves and screening for lung cancer in at-risk individuals advances, there will be increased requirements for minimally invasive diagnosis.

The Monarch Platform integrates the latest advancements in robotics, software, data science, and endoscope innovation with the goal of enabling earlier and more-accurate diagnosis, and eventually treatment, of small and hard-to-reach nodules in the periphery of the lung.

Source: El Camino Hospital

Photo: El Camino Hospital Pioneers First U.S. Use of Robotic Platform for Lung Cancer Diagnosis (Photo: Business Wire)

Comments

No comments to display.